These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 25930174

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study.
    Tang GH, Norris E, Petrucci J, James PD, Lee A, Poon MC, Floros G, Boma-Fischer L, Teitel J, Nisenbaum R, Sholzberg M.
    BMJ Open; 2019 Dec 02; 9(12):e032891. PubMed ID: 31796490
    [Abstract] [Full Text] [Related]

  • 5. Increased burden on caregivers of having a child with haemophilia complicated by inhibitors.
    Lindvall K, von Mackensen S, Elmståhl S, Khair K, Stain AM, Ljung R, Berntorp E.
    Pediatr Blood Cancer; 2014 Apr 02; 61(4):706-11. PubMed ID: 24277475
    [Abstract] [Full Text] [Related]

  • 6. Measurement properties of the Haem-A-QoL in haemophilia clinical trials.
    von Mackensen S, Eldar-Lissai A, Auguste P, Krishnan S, von Maltzahn R, Yu R, Wyrwich KW.
    Haemophilia; 2017 May 02; 23(3):383-391. PubMed ID: 28026074
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH, Scheibel E, Ingerslev J, Schwartz M.
    Thromb Haemost; 2000 Mar 02; 83(3):433-7. PubMed ID: 10744150
    [Abstract] [Full Text] [Related]

  • 10. Association between phenotype and genotype in carriers of haemophilia A.
    Miesbach W, Alesci S, Geisen C, Oldenburg J.
    Haemophilia; 2011 Mar 02; 17(2):246-51. PubMed ID: 21118332
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study.
    James PD, Mahlangu J, Bidlingmaier C, Mingot-Castellano ME, Chitlur M, Fogarty PF, Cuker A, Mancuso ME, Holme PA, Grabell J, Satkunam N, Hopman WM, Mathew P, Global Emerging HEmostasis Experts Panel (GEHEP).
    Haemophilia; 2016 Nov 02; 22(6):912-918. PubMed ID: 27868369
    [Abstract] [Full Text] [Related]

  • 12. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia.
    Rentz A, Flood E, Altisent C, Bullinger M, Klamroth R, Garrido RP, Scharrer I, Schramm W, Gorina E, Members of the HAEMO-QoL-A Steering Committee.
    Haemophilia; 2008 Sep 02; 14(5):1023-34. PubMed ID: 18665853
    [Abstract] [Full Text] [Related]

  • 13. Psychometric field study of the new haemophilia quality of life questionnaire for adults: the 'Hemofilia-QoL'.
    Remor E, Arranz P, Quintana M, Villar A, Jiménez-Yuste V, Diaz JL, Rincón C, Marrero C, Moreno M, Lucia JF, Martínez E, Soto I, Sedano C, Gonzalez-Boullosa R, Prieto M, Garcia-Luaces M, Hernández-Navarro F, Hemofilia-QoL Project Group.
    Haemophilia; 2005 Nov 02; 11(6):603-10. PubMed ID: 16236110
    [Abstract] [Full Text] [Related]

  • 14. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.
    Olsson A, Hellgren M, Berntorp E, Ljung R, Baghaei F.
    Blood Coagul Fibrinolysis; 2014 Jul 02; 25(5):471-5. PubMed ID: 24509327
    [Abstract] [Full Text] [Related]

  • 15. Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS).
    Mahlangu J, Oldenburg J, Callaghan MU, Shima M, Mancuso ME, Trask P, Recht M, Garcia C, Yang R, Lehle M, Macharia H, Asikanius E, Levy GG, Kruse-Jarres R, von Mackensen S.
    Haemophilia; 2019 May 02; 25(3):382-391. PubMed ID: 31016855
    [Abstract] [Full Text] [Related]

  • 16. Severe and moderate haemophilia A and B in US females.
    Di Michele DM, Gibb C, Lefkowitz JM, Ni Q, Gerber LM, Ganguly A.
    Haemophilia; 2014 Mar 02; 20(2):e136-43. PubMed ID: 24533955
    [Abstract] [Full Text] [Related]

  • 17. Carrier detection and prenatal diagnosis in families with haemophilia.
    Shetty S, Ghosh K, Bhide A, Mohanty D.
    Natl Med J India; 2001 Mar 02; 14(2):81-3. PubMed ID: 11396323
    [Abstract] [Full Text] [Related]

  • 18. Interpreting important health-related quality of life change using the Haem-A-QoL.
    Wyrwich KW, Krishnan S, Poon JL, Auguste P, von Maltzahn R, Yu R, von Mackensen S.
    Haemophilia; 2015 Sep 02; 21(5):578-84. PubMed ID: 25828456
    [Abstract] [Full Text] [Related]

  • 19. Haemophilia care in Europe: the ESCHQoL study.
    Schramm W, Gringeri A, Ljung R, Berger K, Crispin A, Bullinger M, Giangrande PL, Von Mackensen S, Mantovani LG, Nemes L, Serban M, ESCHQOL Study Group.
    Haemophilia; 2012 Sep 02; 18(5):729-37. PubMed ID: 22639833
    [Abstract] [Full Text] [Related]

  • 20. Prophylaxis with anti-inhibitor coagulant complex improves health-related quality of life in haemophilia patients with inhibitors: results from FEIBA NF Prophylaxis Study.
    Stasyshyn O, Antunes S, Mamonov V, Ye X, Epstein J, Xiong Y, Tangada S.
    Haemophilia; 2014 Sep 02; 20(5):644-50. PubMed ID: 24589084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.